`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioner
`
`V.
`
`ALCON RESEARCH, LTD.,
`Patent Owner
`
`Case IPR2017-01053
`
`Patent 8,268,299
`
`DECLARATION OF CHRISTOPHER J. MANDERNACH IN SUPPORT OF
`
`MOTION FOR PRO HAC VICE ADMISSION
`
`PURSUANT TO 37 C.F.R. § 42.10(c)
`
`1.
`
`I, Christopher J. Mandernach, am more than twenty-one years of age,
`
`am competent to present this declaration, and have personal knowledge of the facts
`
`set forth herein. I have over eight (8) years of patent litigation experience.
`
`2.
`
`This declaration is given in support of the patent owner Alcon
`
`Research, Ltd.’s Motion for Pro Hac Vice Admission.
`
`3.
`
`I am a member in good standing of the bars of Minnesota and the
`
`District of Columbia.
`
`
`
`4.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`5.
`
`No court or administrative body has ever denied my application for
`
`admission to practice before it.
`
`6.
`
`No court or administrative body has ever imposed sanctions or
`
`contempt citations on me.
`
`7.
`
`I have read and will comply with the Office Patent Trial Practice
`
`guide and the Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R.
`
`8.
`
`I understand that I will be subject to the USPTO Code of Professional
`
`Responsibility set forth in 37 C.F.R. §§ 11.101 et seq. and will be subject to
`
`disciplinary jurisdiction under 37 C.F.R. § 1 1.19(a).
`
`9.
`
`I have applied to appear pro hac vice in one (1) other proceeding
`
`before the Office in the last three (3) years: Argentum Pharmaceuticals LLC v.
`
`Alcon Research, Ltd. , IPR2016-00544, challenging US. Patent No. 8,791,154.
`
`10.
`
`I am familiar with the subject matter at issue in the present
`
`proceeding. I represented Alcon in litigation in the US. District Court for the
`
`District of Delaware in which the same patent was at issue: Alcon Research, Ltd.
`
`v. Mylan Pharmaceuticals Inc. et al. , No. 1:13-cv-01332 (SLR); Alcon Research,
`
`Ltd. v. Wockhardt Ltd. et al., No. l:l3-cv—02040 (SLR); Alcon Research, Ltd. v.
`
`Micro Labs Ltd. et al., No. 1:14-cv—00014 (SLR); and Alcon Research, Ltd. v.
`
`
`
`Watson Laboratories, Inc. et al., No. 1:14-cv-00647 (SLR). In addition, I
`
`previously represented Alcon before the Patent Trial and Appeal Board in Apotex
`
`Corp. v. Alcon Research, Ltd, IPR2013—00428, which challenged the same patent
`
`at issue here.
`
`1 1.
`
`I hereby declare that all statements made herein of my own
`
`knowledge are true and that all statements made on information and belief are
`
`believed to be true, and further that these statements were made with the
`
`knowledge that willful false statements and the like so made are punishable by fine
`
`or imprisonment, or both, under 18 U.S.C. §?1-~ _ m
`
`
`
`A C
`
`hristopher J. Mandernach
`
`